Skip to main content

Advertisement

Log in

The role of toxicology interpretations in prevention of sudden death

  • Original Article
  • Published:
Forensic Science, Medicine, and Pathology Aims and scope Submit manuscript

Abstract

Inappropriate combinations of pharmaceutical drugs are often detected in deaths reported to a coroner. However, the involvement of drug combinations in the cause of death can be overlooked in cases when significant natural disease or external injury is also present. This study examined pathology reports and coroner’s findings between January 2002 and December 2008. Cases that included exposure to a selection of serotonergic drugs were examined to determine the role of different death investigators in drug-associated deaths in Victoria, Australia. Of the 326 cases identified, the involvement of drugs in the death was discussed to some degree in 66% of cases. Recommendations by the coroner pertaining to death prevention were made in 12 cases (4%). In 16 cases (5%) the drugs were not mentioned in the findings, including at least 11 cases of probable major adverse drug interactions. Death investigations serve an important public health and safety role, however, the potential involvement of drugs in many cases is not always recognized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Australian Bureau of Statistics. Drug-induced death, Australia, 1991–2001. Canberra, Australia (2003) Contract No. 3321.0.55.001.

  2. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.

    Article  PubMed  Google Scholar 

  3. Drummer OH. Post-mortem toxicology. Forensic Sci Int. 2007;165(2–3):199–203.

    Article  PubMed  CAS  Google Scholar 

  4. Madea B, Musshoff F. Postmortem toxicology. Forensic Sci Int. 2004;142(2–3):71–3.

    Article  PubMed  Google Scholar 

  5. Curphey TJ. Role of the forensic pathologist in the medicolegal certification of modes of death. J Forensic Sci. 1968;13(2):163–76.

    PubMed  CAS  Google Scholar 

  6. Vanezis P. The role of the pathologist in the investigation of unexpected death in infancy (cot death). Med Sci Law. 1981;21(2):119–20.

    PubMed  CAS  Google Scholar 

  7. Manini AF, Nelson LS, Olsen D, Vlahov D, Hoffman RS. Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011;206(1–3):71–6.

    Article  PubMed  Google Scholar 

  8. Bugeja L, Ranson D. Coroners’ recommendations: a lost opportunity. J Law Med. 2005;13(2):173–5.

    PubMed  Google Scholar 

  9. Studdert DM, Cordner SM. Impact of coronial investigations on manner and cause of death determinations in Australia, 2000–2007. Med J Aust. 2010;192(8):444–7.

    PubMed  Google Scholar 

  10. Brodie L, Bugeja L, Ibrahim JE. Coroners’ recommendations following fatal heavy vehicle crash investigations. Aust N Z J Psychiatry. 2010;34(2):136–41.

    Google Scholar 

  11. Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–7.

    Article  PubMed  CAS  Google Scholar 

  12. Department of Health and Ageing (DHA). Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2007.

  13. Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125(6):803–15.

    Article  PubMed  Google Scholar 

  14. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327–41.

    Article  PubMed  CAS  Google Scholar 

  15. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.

    Article  PubMed  CAS  Google Scholar 

  16. Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997;17(2):113–7.

    Article  PubMed  CAS  Google Scholar 

  17. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112–20.

    Article  PubMed  CAS  Google Scholar 

  18. Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome p450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2010;7(2):162–84.

    Article  PubMed  Google Scholar 

  19. Micromedex® healthcare series [database on the Internet] 1974–2010. 2010. http://www.thomsonhc.com.ezproxy.lib.monash.edu.au. Accessed: 16 July 2010

Download references

Acknowledgments

We thank the organization that maintains the National Coroners Information System for their help in obtaining mortality data. We also acknowledge the assistance of pathologists, forensic technicians and toxicologists at the Victorian Institute of Forensic Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer L. Pilgrim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pilgrim, J.L., Gerostamoulos, D. & Drummer, O.H. The role of toxicology interpretations in prevention of sudden death. Forensic Sci Med Pathol 8, 263–269 (2012). https://doi.org/10.1007/s12024-011-9309-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12024-011-9309-7

Keywords

Navigation